In Health & NHS news

Follow this topic

Bookmark

Record learning outcomes

A batch of ramipril 2.5mg capsules have been recalled after a pack was found to contain a quadruple-strength dose.

Crescent Pharma is recalling batch number GR155023 of its ramipril 2.5mg capsules after a healthcare professional found two blister strips of the 10mg in a sealed pack.

“Both product batches were manufactured at the same site, and the error appears to have occurred during packaging of the cartons,” said the MHRA.

MHRA chief safety officer Alison Cave told affected patients to contact their dispensing pharmacy, advising them: “If you have an affected pack or previously received this batch and you believe you have taken any Ramipril 10mg capsules that were included in error and are currently experiencing any side effects, please seek medical advice.

“Signs and symptoms may include feeling lightheaded, fainting or being fatigued, or altered kidney function and may be more serious for vulnerable patients.

“Any possible impact of taking a higher dose of ramipril should be assessed by a healthcare professional to determine whether any examination or tests are needed.”